Warwick

Based at Warwick Medical School, the Warwick Clinical Trials Unit (WCTU) was established in 2005. An award winning clinical trials unit, WCTU received full registration status from the UKCRC in November 2007.

Our purpose built facilities were made possible thanks to funding from the Wolfson Foundation and Advantage West Midlands through its Birmingham Science City Translational Medicine, Clinical Research and Infrastructure Trials Platform.

WCTU is interdisciplinary with collaboration between clinical trialists, statisticians, economists, clinical experts and project managers.

With expertise in both designing and conducting trials, we specialise in trials investigating complex health states and interventions. Our programmes of work draw together quantitative and qualitative methodologies in an evaluation framework. High quality, randomised evidence is generated to inform modern clinical and health care practice.

  • WCTU's major strands of work are:
  • Cancer
  • Emergency and Critical Care
  • Methodology
  • Maternal Health
  • Surgery, Pain and Rehabilitation

Role

Warwick is involved in several work packages of the Path for Young project and is particularly involved in managing the Optima trial in England, in the statistical analysis of Optima Young, and in the associated medical-economic analysis.

Members

Professor Rob Stein

OPTIMA-Main Chief investigator

Professor Iain MacPherson

OPTIMA-Main Co Chief investigator

Professor Andreas Makris

OPTIMA-Main Co Chief investigator

Dr Luke Hughes-Davies

OPTIMA-Main Co Chief investigator

Professor Janet Dunn

Professor of Clinical Trials & Head of Cancer Trials

Associate Professor Andrea Marshall

OPTIMA-Main Trial Statistician

Helen Higgins

Georgina Dotchin

OPTIMA-Main Trial Manager